Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Taylor

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Biochemical and Biophysical Research Communications|April 20, 2004
Proteolytic inactivation of the bovine spongiform encephalopathy agentAnne H McLeod, Heather Murdoch, Jo Dickinson, et al.
Annals of Emergency Medicine|March 25, 2017
In replyDavid M Taylor, Celene Y L Yap, David C M Kong, et al.
ACS Chemical Biology|March 5, 2011
A brain-permeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylaseDavid M Taylor, Uma Balabadra, Zhongmin Xiang, et al.
The Lancet. Psychiatry|September 29, 2023
Antidepressant and antipsychotic side-effects and personalised prescribing: a systematic review and digital tool developmentToby Pillinger, Oliver D Howes, Christoph U Correll, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 9, 2013
MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibitionDavid M Taylor, Roger Moser, Etienne Régulier, et al.
Journal of Neuropathology and Experimental Neurology|August 20, 2010
Decreased Lin7b expression in layer 5 pyramidal neurons may contribute to impaired corticostriatal connectivity in huntington diseaseBirgit Zucker, Jibrin A Kama, Alexandre Kuhn, et al.
Schizophrenia Research|July 31, 2017
Hyperprolactinaemia in first episode psychosis - A longitudinal assessmentJohn Lally, Olesya Ajnakina, Brendon Stubbs, et al.
Ecological Applications : a Publication of the Ecological Society of America|July 5, 2017
Impact of disease on the survival of three commercially fished speciesJohn M Hoenig, Maya L Groner, Matthew W Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2010
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesisRuth Luthi-Carter, David M Taylor, Judit Pallos, et al.
Lancet (London, England)|October 24, 2025
The effects of antidepressants on cardiometabolic and other physiological parameters: a systematic review and network meta-analysisToby Pillinger, Atheeshaan Arumuham, Robert A McCutcheon, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Biochemical and Biophysical Research Communications|April 20, 2004
Proteolytic inactivation of the bovine spongiform encephalopathy agentAnne H McLeod, Heather Murdoch, Jo Dickinson, et al.
Annals of Emergency Medicine|March 25, 2017
In replyDavid M Taylor, Celene Y L Yap, David C M Kong, et al.
ACS Chemical Biology|March 5, 2011
A brain-permeable small molecule reduces neuronal cholesterol by inhibiting activity of sirtuin 2 deacetylaseDavid M Taylor, Uma Balabadra, Zhongmin Xiang, et al.
The Lancet. Psychiatry|September 29, 2023
Antidepressant and antipsychotic side-effects and personalised prescribing: a systematic review and digital tool developmentToby Pillinger, Oliver D Howes, Christoph U Correll, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 9, 2013
MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibitionDavid M Taylor, Roger Moser, Etienne Régulier, et al.
Journal of Neuropathology and Experimental Neurology|August 20, 2010
Decreased Lin7b expression in layer 5 pyramidal neurons may contribute to impaired corticostriatal connectivity in huntington diseaseBirgit Zucker, Jibrin A Kama, Alexandre Kuhn, et al.
Schizophrenia Research|July 31, 2017
Hyperprolactinaemia in first episode psychosis - A longitudinal assessmentJohn Lally, Olesya Ajnakina, Brendon Stubbs, et al.
Ecological Applications : a Publication of the Ecological Society of America|July 5, 2017
Impact of disease on the survival of three commercially fished speciesJohn M Hoenig, Maya L Groner, Matthew W Smith, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 10, 2010
SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesisRuth Luthi-Carter, David M Taylor, Judit Pallos, et al.
Lancet (London, England)|October 24, 2025
The effects of antidepressants on cardiometabolic and other physiological parameters: a systematic review and network meta-analysisToby Pillinger, Atheeshaan Arumuham, Robert A McCutcheon, et al.
Pageof 10